ABOUT US

关于我们

董事长 黄文林

chairman Huang Wenlin

董事长寄语

CHAIRMAN MESSAGE

       基因治疗药物是在人类基因组学及疾病基因组学的基础上,九十年代发展起来的一种新兴的治疗技术及药物,是精准医学的重要组成部分。其原理是利用人体的正常基因替代突变或沉默的基因,以达到治疗单基因或多基因变异引起的疾病,包括糖尿病,心血管疾病、肿瘤、儿童罕见病等。在通向精准医疗的路上,有美好的愿景,任重而道远,还需要我们不断吸取新技术,进行产学研的有效整合,为市场提供高品质的生物医疗产品。目前公司有五项研究进行中的项目,包括针对肿瘤抗新生血管生成、肿瘤转录点、免疫再平衡及细胞周期色素放疗保护等产品,形成以肿瘤生产的关键微环境为靶点的新药研发系列产品。


       公司的宗旨的以现代的基因操作技术及靶向载体为平台,针对人类肿瘤发生的关键驱动基因,通过大数据的前瞻性研究和严格的多中心临床试验,发展异常靶点的新型基因药物,打造具有自主知识产权和国际认可的专业性研发公司。公司抱有提高肿瘤病患的生存率及生存质量,让肿瘤患者享受21世纪的新技术带来的治疗性成果的愿景。

我仅代表达博生物制品有限公司全体员工,共同祝愿人类的健康保障走向新纪元,让我们的生活更加丰富多彩!


董事长介绍

CHAIRMAN MESSAGE

       黄文林教授,公司董事长兼CEO,肿瘤学家,国务院特殊津贴专家,国家高层次人才,国家新药评审中心审评专家,科技部973传染病领域咨询专家,中国生物医药协会基因治疗学会副会长,中山大学肿瘤防治中心教授,香港中文大学名誉教授,广州市创新创业领军人才。


       1988年至2001年在美国学习深造,2001年回国任中山大学肿瘤防治中心教授,是中山大学基因治疗奠基人之一。申请中国、美国及国际发明专利24项,研究转化的国家1类新药重组人内皮抑素腺病毒(E10A)注射液已进入Ⅲ期临床试验(批件号:2012L02744)。在Nat Med、PNAS、JCI、JVI、JI、Mol Ther、Biomaterials、等国际著名SCI刊物发表论文100余篇。主编全国研究生教材《分子病毒学》、《信号传导》、《肿瘤分子靶向治疗》、《黑色素瘤》等。曾先后获得教育部十大优秀留学人员称号、第十二届中国发明专利国家金奖、国家科学技术进步奖、教育部自然科学一等奖,中华医学奖一等奖和广东省科学技术奖一等奖等。


荣誉证书

Certificate Of Honor

  • 荣誉证书

  • 荣誉证书

  • 荣誉证书

  • 荣誉证书

  • 荣誉证书

  • 荣誉证书

已授权发明专利

AUTHORIZED INVENTION PATENT

中国发明专利:

序号 专利类别  授权国别 专利名称及专利号  授权号 状态
1 发明专利  中国  一种人神经营养素-3基因重组病毒 ZL200610034981.7 已授权
2 发明专利  中国  一种作为抗肿瘤药物的喹唑啉衍生物及其制备方法 ZL200580049761.5 已授权
3 发明专利  中国  一种喹唑啉生物的制备方法及用作制备治疗肿瘤疾病药物的应用 ZL200580049759.8   已授权
4 发明专利  中国 一种人血管内皮细胞生长抑制因子的重组病毒; ZL01127894.3 已授权
5 发明专利  中国  人隐花色素蛋白I(hCRY1)的重组表达方法及其在制备放疗保护剂中的应用 ZL201410116197.5 已授权
6 发明专利  中国  一种喹唑啉生物的制备方法及用作制备治疗肿瘤疾病药物的应用 US7825245 已授权
7 发明专利  美国  双苯环衍生物的抗血管生成的作用 US.6440658 已授权
8 发明专利  美国  一种核苷多肽抑制在HeLa细胞中检查腺病毒方法 US 0374052 已授权
9 发明专利  中国  提高基因表达的系统和保持有该系统的载体 ZL201080061897.9 已授权-实施许可
10 发明专利  中国  用于恶性间皮瘤的新型治疗剂和免疫刺激剂 ZL200980136054.8 已授权-实施许可
11 发明专利  中国  诱导单核细胞的树突状细胞样分化并提高抗癌免疫活性的用于癌症治疗或预防的医 ZL200980116783.7 已授权-实施许可
12 发明专利  中国  在对抗癌剂有抗性的癌中具有抗癌剂增强活性的癌细胞死亡诱导剂 ZL200880122369.2 已授权-实施许可
13 发明专利  中国  REIC/Dkk-3基因的部分片段和包含所述部分片段的癌症治疗剂 ZL200780043463.4 已授权-实施许可
14 发明专利  中国  非病毒载体及其制备方法与应用 ZL200910093081.3 已授权
15 发明专利  中国  抑制H1N1型流感病毒增殖的microRNA及其应用 ZL200910090628.4 已授权
16 发明专利  中国  SARS核酸疫苗及其制备方法 ZL200410044291.0 已授权
17 发明专利  中国  腺病毒载体SARS疫苗及其制备方法,以及相关冠状病毒S基因在制备疫苗中的应用 ZL200410044285.5 已授权
18 发明专利  中国  基于CDC27基因用于结直肠癌辅助诊断和/或预后判断的试剂盒 2015105321361 实审中
19 发明专利  中国  一种基于WDR5基因用于结直肠癌辅助诊断的试剂盒 2015104288794 实审中
20 发明专利  中国  一种用于结直肠癌辅助诊断和/或预后判断的试剂盒 2015103696423 实审中
21 发明专利  中国  长链非编码RNA及在制备抑制结直肠癌细胞转移药物的应用 2015103045530 实审中
22 发明专利  中国  一种新型组织特异性小环载体hIFNγ基因治疗药物 2010102593427 实审中

国际发明专利:

取代苯胺基喹唑啉类及其在肿瘤治疗中使用(us7825245b2)

确定对HeLa细胞的腺病毒感染的效果分析方法(产品研发us6440658b1)

出版的代表性著作

AUTHORIZED INVENTION PATENT

  • 黄文林(主编):

    全国研究生教材《分子病毒学》(第三版),人民卫生出版社,2016。

  • 黄文林(主编):

    《肿瘤分子靶向治疗》,人民卫生出版社,2009

  • 黄文林、朱孝峰(主编):

    《信号转导与疾病》(第2版) ,人民卫生出版社,2012。

  • 黄文林(主编):

    《个体化医学原则》 ,人民卫生出版社,2013。

  • 张晓实,陈映波,黄文林(主编):

    《黑色素瘤基础与临床》,人民卫生出版社,2010。

  • 麦海强、黄文林(主编):

    《生物制药有神迹——基因药物的诞生与发展》,广东科技出版社,2011。

所发文章列表

THE POST LIST

1.         Liu T, Wu X, Li Y, Lu W, Zheng F, Zhang C, Long Q, Qiu H, Li Y, Ge Q, Chen M, Yu X, Chen W, Zhang H, Huang W, Luo M, Deng W, Li L. RBFOX3 Regulates the Chemosensitivity of Cancer Cells to 5-Fluorouracil via the PI3K/AKT, EMT and Cytochrome-C/Caspase Pathways. Cell Physiol Biochem. 2018 Apr 18;46(4):1365-1380.

2.         Shuai W, Wu J, Chen S, Liu R, Ye Z, Kuang C, Fu X, Wang G, Li Y, Peng Q, Shi W, Li Y, Zhou Q, Huang W. SUV39H2 promotes colorectal cancer proliferation and metastasis via tri-methylation of the SLIT1 promoter. Cancer Lett. 2018 May 28;422:56-69.

3.         Li Y, Ye Z, Chen S, Pan Z, Zhou Q, Li YZ, Shuai WD, Kuang CM, Peng QH, Shi W, Mao X, Liu RY, Huang W. ARHGEF19 interacts with BRAF to activate MAPK signaling during the tumorigenesis of non-small cell lung cancer. Int J Cancer. 2018 Apr 1;142(7):1379-1391.

4.         Ye W, Ling S, Liu RY, Pan ZZ, Wang G, Gao S, Wu J, Cao L, Dong L, Li Y, ZhouY, Du W, Meng X, Chen J, Guan X, He Y, Pan C, Zheng XS, Lu X, Chen S, Huang W. Exome sequencing reveals the genetic landscape and frequent inactivation of PCDHB3 in Chinese rectal cancers. J Pathol. 2018 Mar 14: doi.

5.         Qiu L, Tan X, Lin J, Liu RY, Chen S, Geng R, Wu J, Huang W. CDC27 Induces Metastasis and Invasion in Colorectal Cancer via the Promotion of Epithelial-To-Mesenchymal Transition. J Cancer. 2017 Aug 21;8(13):2626-2635.

6.         Wu J, Tan X, Lin J, Yuan L, Chen J, Qiu L, Huang W. Minicircle-oriP-miR-31 as a Novel EBNA1-Specific miRNA Therapy Approach for Nasopharyngeal Carcinoma. Hum Gene Ther. 2017 May;28(5):415-427.

7.         Gao S, Li J, Song L, Wu J, Huang W. Influenza A virus-induced downregulation of miR-26a contributes to reduced IFNα/β production. Virol Sin. 2017 Aug;32(4):261-270.

8.         Lin J, Tan X, Qiu L, Huang L, Zhou Y, Pan Z, Liu R, Chen S, Geng R, Wu J, Huang W. Long Noncoding RNA BC032913 as a Novel Therapeutic Target for Colorectal Cancer that Suppresses Metastasis by Upregulating TIMP3. Mol Ther Nucleic Acids. 2017 Sep 15;8:469-481.

9.         Shi W, Ye Z, Zhuang L, Li Y, Shuai W, Zuo Z, Mao X, Liu R, Wu J, Chen S,Huang W. Olfactomedin 1 negatively regulates NF-κB signalling and suppresses the growth and metastasis of colorectal cancer cells. J Pathol. 2016 Nov;240(3):352-365.

10.     Yao C, Sheng C, Liu D, Gao S, Jiang W, Yu H, Li J, Chen H, Wu J, Pan C, Chen  S, Huang W. [Expression, purification of recombinant human cryptochrome I and its application in preparation of protective agent for radiotherapy]. Sheng Wu Gong Cheng Xue Bao. 2015 Jan;31(1):135-46.

11.     Wang L, Xu Y, Luo C, Sun J, Zhang J, Lee MW, Bai A, Chen G, Frenz CM, Li Z, Huang W. MAGEA10 gene expression in non-small cell lung cancer and A549 cells, and the affinity of epitopes with the complex of HLA-A 0201 alleles. Cell Immunol. 2015 Sep;297(1):10-8.

12.     Liu D, Sheng C, Gao S, Yao C, Li J, Jiang W, Chen H, Wu J, Pan C, Chen S,Huang W. SOCS3 Drives Proteasomal Degradation of TBK1 and Negatively Regulates Antiviral Innate Immunity. Mol Cell Biol. 2015 Jul;35(14):2400-13.

13.     Liu J, Wu J, Zhou L, Pan C, Zhou Y, Du W, Chen JM, Zhu X, Shen J, Chen S, Liu RY, Huang W. ZD6474, a new treatment strategy for human osteosarcoma, and its potential synergistic effect with celecoxib. Oncotarget. 2015 Aug 28;6(25):21341-52.

14.     Chen H, Gao S, Li J, Liu D, Sheng C, Yao C, Jiang W, Wu J, Chen S, Huang W.Wedelolactone disrupts the interaction of EZH2-EED complex and inhibits PRC2-dependent cancer. Oncotarget. 2015 May 30;6(15):13049-59.

15.     Gao S, Wu J, Liu RY, Li J, Song L, Teng Y, Sheng C, Liu D, Yao C, Chen H,Jiang W, Chen S, Huang W. Interaction of NS2 with AIMP2 facilitates the switch from ubiquitination to SUMOylation of M1 in influenza A virus-infected cells. J Virol. 2015 Jan;89(1):300-11.

16.     Li J, Song L, Zhou L, Wu J, Sheng C, Chen H, Liu Y, Gao S, Huang W. A MicroRNA Signature in Gestational Diabetes Mellitus Associated with Risk of Macrosomia. Cell Physiol Biochem. 2015;37(1):243-52.

17.     Wu Q, Huang W. [Producing Ad-IFN gamma by suspension culture of HEK293 cells in a disposable bioreactor]. Sheng Wu Gong Cheng Xue Bao. 2014 Nov;30(11):1786-90.

18.     KatsuyukiHamadaToshiroShirakawaShujiTeraoAkinobuGotohKenzaburoTaniHuangW. Biosafety studies of carrier cells infected with a replication-competent adenovirus introduced by IAI 3B promoter. Mol Ther Methods Clin Dev. 2014 May 28;1:14019.

19.     Liu D, Sheng C, Gao S, Jiang W, Li J, Yao C, Chen H, Wu J, Chen S, Huang W. eEF1Bγ is a positive regulator of NF-кB signaling pathway. Biochem Biophys Res Commun. 2014 Apr 4;446(2):523-8.

20.     Ye W, Liu R, Pan C, Jiang W, Zhang L, Guan Z, Wu J, Ying X, Li L, Li S, Tan W, Zeng M, Kang T, Liu Q, Thomas GR, Huang M, Deng W, Huang W. Multicenter randomized phase 2 clinical trial of a recombinant human endostatin adenovirus in patients with advanced head and neck carcinoma. Mol Ther. 2014 Jun;22(6):1221-1229.

21.     Wang L, Gao S, Jiang W, Luo C, Xu M, Bohlin L, Rosendahl M, Huang W. Antioxidative dietary compounds modulate gene expression associated with apoptosis, DNA repair, inhibition of cell proliferation and migration. Int J Mol  Sci. 2014 Sep 15;15(9):16226-45.

22.     Zhou Y, Wu J, Fu X, Du W, Zhou L, Meng X, Yu H, Lin J, Ye W, Liu J, Peng H, Liu RY, Pan C, Huang W. OTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer. Mol Cancer. 2014 Nov 28;13:258.

23.     Yu H, Ye W, Wu J, Meng X, Liu RY, Ying X, Zhou Y, Wang H, Pan C, Huang W. Overexpression of sirt7 exhibits oncogenic property and serves as a prognostic factor in colorectal cancer. Clin Cancer Res. 2014 Jul 1;20(13):3434-45.

24.     Liu RY, Peng JL, Li YQ, Huang BJ, Lin HX, Zhou L, Luo HL, Huang W.Tumor-specific cytolysis caused by an E1B55K-attenuated adenovirus in nasopharyngeal carcinoma is augmented by cisplatin. Anat Rec (Hoboken). 2013Dec;296(12):1833-41.

25.     Xie FJ, Zhao P, Zhang YP, Liu FY, Nie XL, Zhu YH, Yu XM, Zheng QQ, Mao WM,Lu HY, Wei H, Huang W. Adenovirus-mediated interferon-γ gene therapy induced human pancreatic carcinoma Capan-2 cell apoptosis in vitro and in vivo. Anat Rec (Hoboken). 2013 Apr;296(4):604-10.

26.     Ying X, Wu J, Meng X, Zuo Y, Xia Q, Chen J, Feng Y, Liu R, Li L, Huang W. AC133 expression associated with poor prognosis in stage II colorectal cancer. Med Oncol. 2013 Mar;30(1):356.

27.     Li LX, Zhang YL, Zhou L, Ke ML, Chen JM, Fu X, Ye CL, Wu JX, Liu RY, Huang W.Antitumor efficacy of a recombinant adenovirus encoding endostatin combined with an E1B55KD-deficient adenovirus in gastric cancer cells. J Transl Med. 2013 Oct 14;11:257.

28.     Chen S, Sheng C, Liu D, Yao C, Gao S, Song L, Jiang W, Li J, Huang W. Enhancer of zeste homolog 2 is a negative regulator of mitochondria-mediated innate immune responses. J Immunol. 2013 Sep 1;191(5):2614-23.

29.     Yu H, Meng X, Wu J, Pan C, Ying X, Zhou Y, Liu R, Huang W. Cryptochrome 1 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer. PLoS One. 2013 Apr 23;8(4):e61679.

30.     Jiang W, Wang Q, Chen S, Gao S, Song L, Liu P, Huang W. Influenza A virus NS1 induces G0/G1 cell cycle arrest by inhibiting the expression and activity of RhoA protein. J Virol. 2013 Mar;87(6):3039-52.

31.     Meng X, Wu J, Pan C, Wang H, Ying X, Zhou Y, Yu H, Zuo Y, Pan Z, Liu RY, Huang W. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD. Gastroenterology. 2013 Aug;145(2):426-36.

32.     Liu RY, Zhu YH, Zhou L, Zhao P, Li HL, Zhu LC, Han HY, Lin HX, Kang L, Wu JX, Huang W. Adenovirus-mediated delivery of interferon-γ gene inhibits the growth of nasopharyngeal carcinoma. J Transl Med. 2012 Dec 28;10:256.

33.     Wang Q, Chen Y, Gao S, Jiang W, Song L, Huang W. [Immunological efficiency induced by HIV-1 p24 DNA combined with P24 protein]. Sheng Wu Gong Cheng Xue Bao. 2011 May;27(5):773-80.

34.     Zuo Y, Wu J, Xu Z, Yang S, Yan H, Tan L, Meng X, Ying X, Liu R, Kang T,Huang W. Minicircle-oriP-IFNγ  a novel targeted gene therapeutic system for EBV positive human nasopharyngeal carcinoma. PLoS One. 2011 May 5;6(5):e19407.

35.     Song L, Gao S, Jiang W, Chen S, Liu Y, Zhou L, Huang W. Silencing suppressors  viral weapons for countering host cell defenses. Protein Cell. 2011 Apr;2(4):273-81.

36.     Wang H, Wu J, Meng X, Ying X, Zuo Y, Liu R, Pan Z, Kang T, Huang W. MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1. Carcinogenesis. 2011 Jul;32(7):1033-42.

37.     Zhang C, Liu H, Gao S, Huang W, Wang Z. [Polyethylenimine and minicircle DNA based gene transfer]. Sheng Wu Gong Cheng Xue Bao. 2010 Jun;26(6):772-9.

38.     Tan L, Xu B, Liu R, Liu H, Tan H, Huang W. Gene therapy for acute myeloid leukemia using Sindbis vectors expressing a fusogenic membrane glycoprotein. Cancer Biol Ther. 2010 Mar 1;9(5):350-7.

39.     Zhao P, Luo R, Wu J, Xie F, Li H, Xiao X, Fu L, Zhu X, Liu R, Zhu Y, Liang Z, Huang W. E10A, an adenovirus carrying human endostatin gene, in combination with docetaxel treatment inhibits prostate cancer growth and metastases. J Cell Mol Med. 2010 Jan;14(1-2):381-91.

40.     Liu H, Song L, Huang W. [MiR26a and miR939 regulate the replication of H1N1 influenza virus in MDCK cell]. Wei Sheng Wu Xue Bao. 2010 Oct;50(10):1399-405.

41.     Han H, Zhong C, Zhang X, Liu R, Pan M, Tan L, Li Y, Wu J, Zhu Y, Huang W. Genistein induces growth inhibition and G2/M arrest in nasopharyngeal carcinoma cells. Nutr Cancer. 2010;62(5):641-7.

42.     Zhang C, Gao S, Jiang W, Lin S, Du F, Li Z, Huang W. Targeted minicircle DNA delivery using folate-poly(ethylene glycol)-polyethylenimine as non-viral carrier. Biomaterials. 2010 Aug;31(23):6075-86.

43.     Yan H, Wu J, Liu W, Zuo Y, Chen S, Zhang S, Zeng M, Huang W. MicroRNA-20a overexpression inhibited proliferation and metastasis of pancreatic carcinoma cells. Hum Gene Ther. 2010 Dec;21(12):1723-34.

44.     Song L, Liu H, Gao S, Jiang W, Huang W. Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells. J Virol. 2010 Sep;84(17):8849-60.

45.     Wu J, Xiao X, Jia H, Chen J, Zhu Y, Zhao P, Lin H, Huang W. Dynamic distribution and expression in vivo of the human interferon gamma gene delivered by adenoviral vector. BMC Cancer. 2009 Feb 16;9:55.

46.     Zhang Y, Zhang Y, Guo S, Huang W. Tyrosine kinase inhibitor loaded PCL microspheres prepared by S/O/W technique using ethanol as pretreatment agent. Int J Pharm. 2009 Mar 18;369(1-2):19-23.

47.     Tan L, Jia H, Liu R, Wu J, Han H, Zuo Y, Yang S, Huang W. Inhibition of NF-kappaB in fusogenic membrane glycoprotein causing HL-60 cell death implications for acute myeloid leukemia. Cancer Lett. 2009 Jan 8;273(1):114-21.

48.     Jia HY, Wu JX, Zhu XF, Chen JM, Yang SP, Yan HJ, Tan L, Zeng YX, Huang W.ZD6474 inhibits Src kinase leading to apoptosis of imatinib-resistant K562 cells. Leuk Res. 2009 Nov;33(11):1512-9.

49.     Li Y, Shao JY, Liu RY, Zhou L, Chai LP, Li HL, Han HY, Huang BJ, Zeng MS,Zhu XF, Liu Q, Fu LW, Huang W. Evaluation of long-term toxicity of Ad/hIFN-, an Adenoviral vector encoding the human interferon-gamma gene, in nonhuman primates.Hum Gene Ther. 2008 Aug;19(8):827-39.

50.     Xue G, Liu RY, Li Y, Cheng Y, Liang ZH, Wu JX, Zeng MS, Tian FZ, Huang W. Dendritic cells modified with 6Ckine/IFNgamma fusion gene induce specific cytotoxic T lymphocytes in vitro. Cancer Immunol Immunother. 2007 Nov;56(11):1831-43.

51.     Huang BJ, Liu RY, Huang JL, Liang ZH, Gao GF, Wu JX, Huang W. Long-Term toxicity studies in Canine of E10A, an adenoviral vector for human endostatin gene. Hum Gene Ther. 2007 Mar;18(3):207-21.

52.     Zhao P, Zhu YH, Wu JX, Liu RY, Zhu XY, Xiao X, Li HL, Huang BJ, Xie FJ, Chen JM, Ke ML, Huang W. Adenovirus-mediated delivery of human IFNgamma gene inhibits prostate cancer growth. Life Sci. 2007 Aug 9;81(9):695-701.

53.     Huang J, Wang F, Argyris E, Chen K, Liang Z, Tian H, Huang W, Squires K, Verlinghieri G, Zhang H. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat Med. 2007 Oct;13(10):1241-7.

54.     Li L, Liu RY, Huang JL, Liu QC, Li Y, Wu PH, Zeng YX, Huang W. Adenovirus-mediated intra-tumoral delivery of the human endostatin gene inhibits tumor growth in nasopharyngeal carcinoma. Int J Cancer. 2006 Apr 15;118(8):2064-71.

55.     Wu J, Xiao X, Zhao P, Xue G, Zhu Y, Zhu X, Zheng L, Zeng Y, Huang W. Minicircle-IFNgamma induces antiproliferative and antitumoral effects in human nasopharyngeal carcinoma. Clin Cancer Res. 2006 Aug 1;12(15):4702-13.

56.     Huang JL, Huang J, Duan ZH, Wei J, Min J, Luo XH, Li JG, Tan WP, Wu LZ, Liu RY, Li Y, Shao J, Huang BJ, Zeng YX, Huang W. Th2 predominance and CD8+ memory T cell depletion in patients with severe acute respiratory syndrome. Microbes Infect. 2005 Mar;7(3):427-36.

57.     He GA, Xue G, Xiao L, Wu JX, Xu BL, Huang JL, Liang ZH, Xiao X, Huang BJ, Liu RY, Huang W. Dynamic distribution and expression in vivo of human endostatin  gene delivered by adenoviral vector. Life Sci. 2005 Aug 5;77(12):1331-40.

58.     Liu RY, Wu LZ, Huang BJ, Huang JL, Zhang YL, Ke ML, Wang JM, Tan WP, Zhang RH, Chen HK, Zeng YX, Huang W. Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats. Virus Res. 2005 Sep;112(1-2):24-31.

59.     Huang W, Flint SJ. Unusual properties of adenovirus E2E transcription by RNA polymerase III. J Virol. 2003 Apr;77(7):4015-24.

60.     Huang W, Todaro L, Francesconi LC, Polenova T. 51V magic angle spinning NMR spectroscopy of six-coordinate Lindqvist oxoanions  a sensitive probe for the electronic environment in vanadium-containing polyoxometalates  Counterions dictate the 51V fine structure constants in polyoxometalate solids. J Am Chem Soc. 2003 May 14;125(19):5928-38.